Lv41
450 积分 2024-06-03 加入
Development of a novel Fc fusion protein dual glucagon-like peptide-1 and gastric inhibitory polypeptide receptor agonists
2小时前
已完结
After GLP-1, what’s next for weight loss?
1个月前
已完结
Genetic Code Expansion in Mammalian Cells
1个月前
已完结
Cardiomyocyte-specific RXFP1 overexpression protects against pressure overload-induced cardiac dysfunction independently of relaxin
1个月前
已关闭
Relaxin as a treatment for musculoskeletal fibrosis: What we know and future directions
1个月前
已完结
Therapeutic potential of relaxin or relaxin mimetics in managing cardiovascular complications of diabetes
2个月前
已完结
Rare codon recoding for efficient noncanonical amino acid incorporation in mammalian cells
2个月前
已完结
Relaxin and the Cardiovascular System: from Basic Science to Clinical Practice
2个月前
已完结
Site-specific antibody-drug conjugates
2个月前
已完结
Low incidence of anti-drug antibodies in patients with type 2 diabetes treated with once-weekly glucagon-like peptide-1 receptor agonist dulaglutide
3个月前
已完结
皖公网安备34019202002308
